S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)
S&P 500   5,069.53 (-0.38%)
DOW   39,069.23 (-0.16%)
QQQ   436.55 (-0.05%)
AAPL   181.16 (-0.75%)
MSFT   407.54 (-0.68%)
META   481.74 (-0.47%)
GOOGL   137.57 (-4.44%)
AMZN   174.73 (-0.15%)
TSLA   199.40 (+3.87%)
NVDA   790.92 (+0.35%)
NIO   5.65 (+4.63%)
AMD   176.01 (-0.29%)
BABA   76.51 (+0.72%)
T   16.59 (-1.25%)
F   11.95 (-1.57%)
MU   89.46 (+4.02%)
CGC   3.47 (+3.27%)
GE   154.77 (+0.94%)
DIS   107.69 (-0.05%)
AMC   4.45 (+0.23%)
PFE   27.18 (-2.09%)
PYPL   59.33 (+0.29%)
XOM   104.25 (+0.39%)

Cardiol Therapeutics (CRDL) News Today

$1.76
+0.14 (+8.64%)
(As of 02/26/2024 ET)
SourceHeadline
benzinga.com logoCardiol Therapeutics Stock (NASDAQ:CRDL), Short Interest Report
benzinga.com - February 22 at 5:11 PM
proactiveinvestors.com logoCardiol Therapeutics wraps up patient enrollment for Phase II open label study
proactiveinvestors.com - February 21 at 9:55 AM
proactiveinvestors.com logoCardiol CEO David Elsley unpacks FDA Orphan Drug Designation for Cardiol
proactiveinvestors.com - February 16 at 3:07 PM
proactiveinvestors.com logoCardiol Therapeutics receives orphan drug status for its lead drug...
proactiveinvestors.com - February 15 at 1:48 PM
theglobeandmail.com logoOrphan Drug Designation Sends Shares of this Dual-Listed Life Science Therapy Company Soaring
theglobeandmail.com - February 15 at 1:48 PM
msn.com logoCardiol stock rallies 28% on FDA orphan drug status for CardiolRx
msn.com - February 15 at 1:48 PM
proactiveinvestors.com logoCardiol Therapeutics receives orphan drug status for its lead drug candidate
proactiveinvestors.com - February 15 at 9:49 AM
marketbeat.com logoShort Interest in Cardiol Therapeutics Inc. (NASDAQ:CRDL) Drops By 9.0%
marketbeat.com - January 30 at 8:23 AM
morningstar.com logoCardiol Therapeutics Inc Class A CRDL
morningstar.com - January 9 at 11:47 PM
finance.yahoo.com logoCardiol Therapeutics Announces it has Exceeded 50% Enrollment in its Phase II ARCHER Trial in Acute Myocarditis
finance.yahoo.com - January 9 at 8:46 AM
theglobeandmail.com logoClosing Bell: Cardiol Therapeutics Inc Purchase WT down on Tuesday (CRDL-WT-A)
theglobeandmail.com - December 18 at 7:09 AM
finance.yahoo.com logoCardiol Therapeutics Announces Study Results Presented at the 2023 Annual Meeting of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases
finance.yahoo.com - November 16 at 8:15 AM
finance.yahoo.com logoCardiol Therapeutics releases positive study results of subcutaneously administered cannabidiol
finance.yahoo.com - October 11 at 1:19 PM
proactiveinvestors.com logoCardiol Therapeutics says study results show positive effects of subcutaneously administered cannabidiol
proactiveinvestors.com - October 10 at 10:23 AM
finance.yahoo.com logoCardiol Therapeutics Announces Positive Study Results Demonstrating Cardioprotective Effects of Subcutaneously Administered Cannabidiol in a Model of Heart Failure with Preserved Ejection Fraction
finance.yahoo.com - October 10 at 10:23 AM
benzinga.com logoCardiol Therapeutics 76% YTD Gain Is A Bullish Signal Ahead Of Expected Phase III Trial Announcements ($CRDL)
benzinga.com - October 2 at 10:02 AM
finance.yahoo.com logoHere's Why You May Invest in Cardiol Therapeutics (CRDL) Stock
finance.yahoo.com - September 27 at 12:36 PM
finance.yahoo.com logoCardiol Therapeutics Announces All Collaborating Clinical Research Centers Now Initiated and Eligible to Enroll Patients in ARCHER, a Phase II Trial of CardiolRx(TM) for the Treatment of Acute Myocarditis
finance.yahoo.com - September 19 at 9:24 AM
finance.yahoo.com logoIs Cardiol Therapeutics (TSE:CRDL) In A Good Position To Deliver On Growth Plans?
finance.yahoo.com - August 26 at 4:55 PM
finance.yahoo.com logoCardiol Therapeutics to Present at Canaccord Genuity 43rd Annual Growth Conference
finance.yahoo.com - August 9 at 8:00 AM
theglobeandmail.com logoClosing Bell: Cardiol Therapeutics Inc flat on Wednesday (CRDL)
theglobeandmail.com - August 4 at 11:07 PM
finance.yahoo.com logoCardiol Therapeutics Reports Results of 2023 Annual General Meeting
finance.yahoo.com - June 29 at 2:01 PM
proactiveinvestors.com logoCardiol Therapeutics earns higher price target from broker as it ends 1Q with sufficient cash to advance CardiolRx candidate
proactiveinvestors.com - May 23 at 4:29 PM
theglobeandmail.com logoClosing Bell: Cardiol Therapeutics Inc down on Thursday (CRDL)
theglobeandmail.com - April 28 at 3:49 AM
theglobeandmail.com logoClosing Bell: Cardiol Therapeutics Inc up on Wednesday (CRDL)
theglobeandmail.com - April 19 at 10:44 PM
theglobeandmail.com logoClosing Bell: Cardiol Therapeutics Inc down on Tuesday (CRDL)
theglobeandmail.com - April 19 at 7:43 AM
theglobeandmail.com logoClosing Bell: Cardiol Therapeutics Inc down on Friday (CRDL)
theglobeandmail.com - April 14 at 9:02 PM
theglobeandmail.com logoClosing Bell: Cardiol Therapeutics Inc up on Monday (CRDL)
theglobeandmail.com - April 11 at 8:05 AM
proactiveinvestors.com logoCardiol Therapeutics offers an update on operations as it advances the development of its lead drug candidate CardiolRx
proactiveinvestors.com - March 29 at 10:41 PM
finance.yahoo.com logoCardiol Therapeutics Announces Year-End 2022 Update on Operations
finance.yahoo.com - March 29 at 7:39 AM
proactiveinvestors.com logoCardiol Therapeutics says new study results highlight the cardioprotective effects of cannabidiol
proactiveinvestors.com - March 7 at 5:06 PM
finance.yahoo.com logoCardiol Therapeutics says first patient enrolled in Phase 2 study of CardiolRx for Pericarditis
finance.yahoo.com - January 17 at 4:21 PM
proactiveinvestors.com logoCardiol Therapeutics enrolls first patient in Phase II CardiolRx study on recurrent pericarditis
proactiveinvestors.com - January 17 at 10:21 AM
proactiveinvestors.com logoCardiol Therapeutics commences Phase II study of CardiolRx for treatment of Recurrent Pericarditis
proactiveinvestors.com - December 14 at 1:49 PM
proactiveinvestors.com logoCardiol Therapeutics kicks off a multi-center Phase II pilot study of CardiolRx for the treatment of recurrent pericarditis
proactiveinvestors.com - December 12 at 4:20 PM
proactiveinvestors.com logoCardiol Therapeutics unveils new study data highlighting protective effects of CardiolRx in acute pericarditis
proactiveinvestors.com - November 7 at 11:06 AM
seekingalpha.com logoCardiol to abandon COVID study of cannabis drug to focus on heart diseases trials
seekingalpha.com - October 25 at 8:38 AM
finance.yahoo.com logoCardiol Therapeutics Announces First Patient Enrolled in ARCHER, a Phase II Clinical Trial of CardiolRx(TM) for Treatment of Acute Myocarditis
finance.yahoo.com - August 3 at 7:57 AM
finance.yahoo.com logoCardiol Therapeutics Inc. (TSE:CRDL): Are Analysts Optimistic?
finance.yahoo.com - July 12 at 7:01 AM
finance.yahoo.com logoCardiol Therapeutics Announces At-The-Market Equity Offering Program
finance.yahoo.com - June 9 at 4:18 PM
benzinga.com logoCardiol Therapeutics (NASDAQ:CRDL), Earnings Estimates, EPS, and Revenue
benzinga.com - June 1 at 4:24 PM
proactiveinvestors.com.au logoCardiol Therapeutics appoints Teri Loxam and CFO Chris Waddick to its board of directors
proactiveinvestors.com.au - May 19 at 9:51 AM
proactiveinvestors.com.au logoCardiol Therapeutics receives US FDA authorization for Phase II study of CardiolRx for recurrent pericarditis
proactiveinvestors.com.au - May 17 at 4:55 PM
proactiveinvestors.com logoCardiol Therapeutics gets FDA go ahead for Investigational New Drug Application for CardiolRx
proactiveinvestors.com - May 17 at 4:55 PM
finance.yahoo.com logoCardiol Therapeutics Announces FDA Investigational New Drug Application (IND) Authorization for Multicenter Phase II Open-Label Pilot Study of CardiolRx(TM) for Recurrent Pericarditis
finance.yahoo.com - May 17 at 7:37 AM
finance.yahoo.com logoWe're Not Worried About Cardiol Therapeutics' (TSE:CRDL) Cash Burn
finance.yahoo.com - May 2 at 3:50 PM
marketbeat.com logoCardiol Therapeutics (NASDAQ:CRDL) Upgraded at Zacks Investment Research
marketbeat.com - March 25 at 8:52 PM
proactiveinvestors.com logoCardiol Therapeutics says Jennifer M. Chao has been appointed as director of the company
proactiveinvestors.com - March 15 at 12:43 PM
finance.yahoo.com logoCardiol Therapeutics Appoints Jennifer M. Chao to Its Board of Directors
finance.yahoo.com - March 15 at 7:43 AM
marketbeat.com logoCardiol Therapeutics (NASDAQ:CRDL) Cut to Sell at Zacks Investment Research
marketbeat.com - March 4 at 8:23 PM
Get Cardiol Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter.



CRDL Media Mentions By Week

CRDL Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

CRDL
News Sentiment

0.64

0.45

Average
Medical
News Sentiment

CRDL News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

CRDL Articles
This Week

2

0

CRDL Articles
Average Week

Get Cardiol Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRDL and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:CRDL) was last updated on 2/26/2024 by MarketBeat.com Staff